Literature DB >> 16838043

Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis.

Mika Norii1, Masahiro Yamamura, Mitsuhiro Iwahashi, Akiko Ueno, Jiro Yamana, Hirofumi Makino.   

Abstract

The inflamed synovial tissue (ST) of rheumatoid arthritis (RA) is characterized by the selective accumulation of interferon gamma-producing Th1-type CD4+ T cells. In this study, we investigated whether the predominance of Th1-type CD4+ cells in the ST lesion is mediated by their selective recruitment through Th1 cell-associated chemokine receptors CXCR3 and CCR5. The lymphocyte aggregates in the ST of RA contained a large number of CD4+ T cells, which mostly expressed both CXCR3 and CCR5, but not CCR4. In contrast, the frequencies of CD4+ and CD8+ T cells expressing CXCR3 and CCR5 in the blood were significantly decreased in RA patients, compared with healthy controls (HC), although there was no difference in the frequencies of CCR4-expressing CD4+ and CD8+ T cells between RA and HC. CXCR3, CCR5, and CCR4 expression in blood CD4 + T cells and CXCR3 expression in CD8+ T cells were increased after interleukin-15 (IL-15) stimulation. Therefore, the distribution of Th1-type CD4+ T cells into the ST from the blood in RA may be associated with the local expression of chemokines, both CXCR3 and CCR5 ligands, and IL-15 may play a role in enhancing these chemokine receptors on CD4+ T cell infiltrates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838043     DOI: 10.18926/AMO/30745

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  16 in total

1.  CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.

Authors:  Vadim A Villarroel; Naoko Okiyama; Gaku Tsuji; Jay T Linton; Stephen I Katz
Journal:  J Invest Dermatol       Date:  2014-01-03       Impact factor: 8.551

2.  Comparative antigen-induced gene expression profiles unveil novel aspects of susceptibility/resistance to adjuvant arthritis in rats.

Authors:  Hua Yu; Changwan Lu; Ming T Tan; Kamal D Moudgil
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

3.  The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.

Authors:  Balázs Szalay; Barna Vásárhelyi; Aron Cseh; Tivadar Tulassay; Magdolna Deák; László Kovács; Attila Balog
Journal:  Clin Rheumatol       Date:  2013-08-11       Impact factor: 2.980

4.  CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis.

Authors:  Paul D Doodes; Yanxia Cao; Keith M Hamel; Yumei Wang; Rachel L Rodeghero; Tamas Kobezda; Alison Finnegan
Journal:  Arthritis Rheum       Date:  2009-10

5.  Chemokine receptor CXCR3 in turbot (Scophthalmus maximus): cloning, characterization and its responses to lipopolysaccharide.

Authors:  Yadong Chen; Shuhong Zhou; Zhiqiang Jiang; Xiuli Wang; Yang Liu
Journal:  Fish Physiol Biochem       Date:  2015-11-19       Impact factor: 2.794

6.  The role of CXCR3 in the induction of primary biliary cirrhosis.

Authors:  Wen Zhang; Yunyun Fei; Jinming Gao; Bin Liu; Fengchun Zhang
Journal:  Clin Dev Immunol       Date:  2011-05-02

7.  Possible influence of resistance to malaria in clinical presentation of rheumatoid arthritis: biological significance of natural selection.

Authors:  Fabio Bonilla-Abadía; Gabriel J Tobón; Carlos A Cañas
Journal:  Arthritis       Date:  2012-11-14

Review 8.  T cells in rheumatoid arthritis.

Authors:  Andrew P Cope
Journal:  Arthritis Res Ther       Date:  2008-10-15       Impact factor: 5.156

Review 9.  Chemokines and chemokine receptors in arthritis.

Authors:  Zoltan Szekanecz; Aniko Vegvari; Zoltan Szabo; Alisa E Koch
Journal:  Front Biosci (Schol Ed)       Date:  2010-01-01

10.  Identification of diagnostic genes and vital microRNAs involved in rheumatoid arthritis: based on data mining and experimental verification.

Authors:  Conglin Ren; Mingshuang Li; Yang Zheng; Fengqing Wu; Weibin Du; Renfu Quan
Journal:  PeerJ       Date:  2021-05-14       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.